Oxytocin

Overview

Oxytocin is an endogenous nine-amino-acid hormone, with a ring structure closed by a sulfur bridge. It is made in the hypothalamus and released via the posterior pituitary.

Classically, oxytocin is known for two peripheral roles: driving uterine contractions in labor and milk ejection during breastfeeding. There is also extensive research into central roles in the brain — social bonding, trust and stress regulation — although the replication of some behavioral findings is contested.

Oxytocin is an established, approved medicine (including for labor induction). That regulatory status is a fact about the respective authorities. At Peptalis, oxytocin is available strictly for research use only — in-vitro, not for human or animal use.

Mechanism of action

Oxytocin activates the oxytocin receptor (OXTR), a G-protein-coupled receptor: peripherally on uterine and breast tissue, centrally in brain regions for social behavior and stress.

Peripheral action

• Via the OXTR on uterine smooth-muscle cells, oxytocin evokes contractions; on the mammary gland it drives milk ejection.
• This action is the basis of the approved obstetric use (Pergialiotis 2021).

Central action

• In the brain, the OXTR is involved in social recognition, bonding, trust and the regulation of stress (Jurek & Neumann 2018).
• Some human behavioral findings — such as an effect on trust after intranasal administration (Kosfeld 2005) — are influential but have contested replication; this is stated honestly here.

Research findings

• Mechanism/review: the oxytocin receptor, from intracellular signaling to behavior (Jurek & Neumann 2018)
• Human (RCT): intranasal oxytocin and trust — influential, replication contested (Kosfeld 2005)
• Human (meta-analysis): oxytocin in labor induction after amniotomy (Pergialiotis 2021)

Mechanism

• The oxytocin receptor and its signaling — peripheral (uterus, breast) and central (behavior, stress) — are extensively described (Jurek & Neumann 2018).

Human studies

• The obstetric use is widely studied; a meta-analysis of RCTs compared dosing schedules in labor induction (Pergialiotis 2021).
• In behavioral research, the study on intranasal oxytocin and trust has been influential (Kosfeld 2005), but the replication of such social effects is contested — an important nuance.

Research context

This profile describes what has been done and found in research. Regulatory and clinical facts are facts about the respective trials and authorities, not claims about a Peptalis product; the compound is for in-vitro laboratory research only (RUO).

Open questions

• The central, behavioral effects of intranasal oxytocin have contested replication; conclusions there must be drawn cautiously.
• The extent to which peripherally administered oxytocin reaches the brain is debated.
• The obstetric action is well established; the neuropsychiatric applications are still under study.

Research outlook

Oxytocin is a well-characterized, approved reference neuropeptide with a well-understood receptor.

For laboratories studying neuropeptide signaling and social-behavior circuits, it is a central model system — with the replication nuance as part of the story.

Scientific interest

A classic, approved neuropeptide with a well-understood receptor (OXTR).

Two worlds in one molecule: peripheral obstetric action and central behavioral roles.

A vast human literature — with an honest replication nuance on the social effects.

Specifications

References

1. Oxytocin increases trust in humans · Kosfeld M, et al. · Nature · 2005
2. The Oxytocin Receptor: From Intracellular Signaling to Behavior · Jurek B, Neumann ID · Physiol Rev · 2018
3. Early versus delayed oxytocin infusion following amniotomy for induction of labor: a meta-analysis of randomized controlled trials · Pergialiotis V, et al. · J Matern Fetal Neonatal Med · 2021

Availability

Not in catalogue · Profile complete · verification and sourcing not yet finished